Oruka Therapeutics Funding: $975M Raised, IPO (2026)

Oruka Therapeutics is a Biotech company based in San Francisco Bay Area. It has raised $975M in total funding. Latest round: IPO.

Oruka Therapeutics funding overview

Oruka Therapeutics is a Biotech company based in San Francisco Bay Area. Oruka Therapeutics has raised $975M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in March 2026. The round record for Oruka Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Syndicate of healthcare investors.

Oruka Therapeutics at a glance

Total raised
$975M
Latest round
IPO
Latest round date
March 2026
Industry
Biotech
Headquarters
San Francisco Bay Area
Notable investors
Syndicate of healthcare investors

Frequently asked about Oruka Therapeutics funding

How much has Oruka Therapeutics raised?
Oruka Therapeutics has raised $975M in total disclosed funding across the rounds on record.
Who has invested in Oruka Therapeutics?
Syndicate of healthcare investors are named among the investors backing Oruka Therapeutics.
What was the latest Oruka Therapeutics funding round?
The most recent disclosed round is an IPO, announced in March 2026.
Where is Oruka Therapeutics based?
Oruka Therapeutics is based in San Francisco Bay Area.
What sector does Oruka Therapeutics operate in?
Oruka Therapeutics is tracked under Biotech from San Francisco Bay Area, with $975M in disclosed funding.
When did Oruka Therapeutics last raise?
The last disclosed Oruka Therapeutics round closed in March 2026 at IPO.

Round data for Oruka Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Francisco Bay Area and backer lists below.

Oruka Therapeutics founders (1)

Companies related to Oruka Therapeutics (35)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026